Search for: "Actavis Pharma"
Results 21 - 40
of 243
Sort by Relevance
|
Sort by Date
20 Aug 2019, 9:59 pm
Actavis Laboratories FL, Inc. [read post]
16 Jun 2019, 11:07 am
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
13 Jun 2019, 1:06 pm
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
26 May 2019, 2:13 pm
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
24 May 2019, 8:38 am
A full breakdown of the event's discussions can be found here.AmeriKat Annsley Merelle Ward has compiled a compendium of all the Fordham IP conference blog posts here.Eleonora Rosati reminds readers of two upcoming events - the European Pharma Law Academy which is returning to Cambridge this September, and the joint IPKat and BLACA (the British Literary and Artistic Copyright Association) event on 'The EU DSM Directive: End of the Story? [read post]
30 Apr 2019, 5:29 am
This focused on the three-step test of the Eli Lilly v Actavis UK Supreme Court decision and the subsequent UK cases applying that test. [read post]
18 Apr 2019, 4:47 am
As regards discretion, Sandoz pointed to alleged financial troubles facing Purdue Pharma arising from the litigation regarding Oxycontin in the United States. [read post]
31 Mar 2019, 7:48 pm
., Tris Pharma, Inc. v. [read post]
6 Feb 2019, 6:12 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
11 Dec 2018, 4:55 am
Rose writes that, in short, the Court dismissed Warner-Lambert's appeal that the patent was sufficiently disclosed, and upheld Actavis and Mylan's appeal that the disputed claims were not even partially sufficient. [read post]
27 Nov 2018, 3:19 am
| Special interview with Mariana Karepova, the President of the Austrian Patent Office | ChIPs Global Summit Report 1: Politics and Technology - When D.C. met Silicon Valley | Book review: Kritika - Essays on Intellectual Property (vol 3) | Tuesday TiddlywinksNever Too Late 202 [Week ending 7 October] Looking to discuss the latest developments in competition law in the pharma sector? [read post]
26 Nov 2018, 9:58 pm
By Kevin E. [read post]
18 Nov 2018, 7:39 am
In her comment Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in Icescape v Ice-World, InternKat Rose analyses this recent case to determine whether Lord Kitchin approached any of the unresolved issues left in the Actavis v Eli Lilly case.CopyrightLast year The IPKat reported on two new important referrals to the Court of Justice of the European Union (CJEU) from Germany. [read post]
25 Jun 2018, 7:15 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
22 Jun 2018, 3:18 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
20 Jun 2018, 4:12 am
On 3 January 2017 Mepha Pharma AG, a Swiss subsidiary of Teva, filed a revocation action against Gilead’s Swiss SPC. [read post]
4 Jun 2018, 3:02 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
28 May 2018, 7:53 am
Actavis. [read post]
26 Apr 2018, 4:48 am
However he did not agree with Arnold J that it is necessary to determine whether the product embodies the inventive advance of the patent, which is referred to in the CJEU’s decision in Actavis v Sanofi (C-443/12), noting that the Actavis case was only concerned with Article 3(c), not 3(a) and commenting that he had difficulty in understanding the difference between the “core inventive advance” and the invention disclosed by the claims. [read post]
3 Mar 2018, 2:35 am
Jane Lambert Patents Court (Mr Justice Arnold): Generics (UK) Ltd (t/a Mylan) and another v Yeda Research And Development Company Ltd [2017] EWHC 2629 (Pat) (26 Oct 2017) On Wednesday, 28 Feb 2018 I gave a talk to the C5 Pharma and Patent Litigation Conference at the Radisson Blu Hotel in Amsterdam. [read post]
